GE HealthCare Technologies (GEHC) - 2023 Q4 - Earnings Call Presentation

Organic Revenue Growth*(1) 8% Approximately 4% Free Cash Flow* $1.7 billion ~$1.8 billion | --- | --- | --- | |-----------------------|-------|----------------------------------| | Adjusted EBIT Margin* | 15.1% | 15.6% - 15.9% 50 - 80 bps growth | | Adjusted ETR* 23.7% | | 23% - 25% | | Adjusted EPS* | $3.93 | $4.20 - $4.35 7% - 11% growth | © 2024 GE HealthCare. GE is a trademark of General Electric Company used under trademark license. 13 Investing in Digital for Future Growth Imaging Ultrasound Imaging A ...